Professor Margaret Hosie

  • Professor of Comparative Virology (Virology)

telephone: 01413302193
email: Margaret.Hosie@glasgow.ac.uk

Room 435 Level 4, Henry Wellcome Building, Garscube, Glasgow G61 1QH

Import to contacts

ORCID iDhttps://orcid.org/0000-0002-4313-5023

Research interests

CVR logo   Virus image CVR Supporting COVID-19 Research Response

Margaret Hosie is Professor of Comparative Virology at the MRC-University of Glasgow Centre for Virus Research. A veterinarian, she completed her Ph.D. studies on feline immunodeficiency virus in 1991 and subsequently she has pursued an academic research and teaching career in Glasgow, collaborating with colleagues in Europe, US, Australia and Japan.  She conducts research in infectious disease pathogenesis, diagnostics and vaccine development, with a focus on feline viruses. In 2002 she was awarded Recognised Specialist Status in Pathology (Microbiology) by the Royal College of Veterinary Surgeons, in recognition of her contributions to these fields.

Her most significant scientific contributions have included the identification of determinants of virulence amongst feline immunodeficiency virus (FIV) isolates, the development of methods to confirm FIV and feline leukaemia virus infections in diagnostic samples, the identification of vaccine-induced enhancement of FIV infection and elucidation of the mechanism of protection induced by whole inactivated FIV vaccines. She has also identified immunological correlates of feline retroviral infection, discovered the primary and co-receptor molecules for FIV infection, and more recently identified the first case of human-to-cat transmission of SARS-CoV-2 in the UK. Over the years, her research findings have had implications for improving feline welfare as well as having wider, comparative and One Health significance.

Prof Hosie has served as a member of the Editorial Boards of Virus Genes and BMC Veterinary Research and has acted as a guest editor for Viruses Special Issues on companion animal virology.  She is currently a member of the UK Veterinary Vaccinology Network, The International Society for Companion Animal Infectious Diseases and recently completed her second term on the British Veterinary Association Policy Committee. She is the INSPIRE lead for the School of Veterinary Medicine and actively encourages veterinary undergraduates to engage with research activities. She is also a member of the panel that is responsible for updating the AAFP: Feline Retrovirus Management Guidelines. She has been a member of the European Advisory Board for Cat Diseases (ABCD) since 2005 and was elected as President of the newly established Association, ABCD Europe, in 2019.

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991
Number of items: 140.

2024

Kuhn, J. et al. (2024) Investigations on the potential role of free-ranging wildlife as a reservoir of SARS-CoV-2 in Switzerland. Viruses, 16(9), 1407. (doi: 10.3390/v16091407)

Ogawa, S., Sherry, L. and Hosie, M. (2024) High Resolution Structure of a Clinical Respiratory Isolate of Feline Calicivirus Determined by Cryo-EM. British Small Animal Veterinary Association (BSAVA) Congress 2024, Manchester, UK, 21-23 Mar 2024. ISBN 9781913859411 (doi: 10.22233/9781913859411.45.3)

Dunbar, D., Babayan, S. A. , Krumrie, S. , Haining, H., Hosie, M. J. and Weir, W. (2024) Assessing the feasibility of applying machine learning to diagnosing non-effusive feline infectious peritonitis. Scientific Reports, 14, 2517. (doi: 10.1038/s41598-024-52577-4) (PMID:38291072)

Hüttl, J. et al. (2024) Serological and molecular investigation of SARS-CoV-2 in horses and cattle in Switzerland from 2020 to 2022. Viruses, 16(2), 224. (doi: 10.3390/v16020224)

2023

Willett, B. J. et al. (2023) Omicron BA.2.86 cross-neutralising activity in community sera from the UK. Lancet, 402(10417), pp. 2075-2076. (doi: 10.1016/s0140-6736(23)02397-8) (PMID:37952549)

Pennisi, M. G. et al. (2023) Feline morbillivirus: clinical relevance of a widespread endemic viral infection of cats. Viruses, 15(10), 2087. (doi: 10.3390/v15102087) (PMID:37896864) (PMCID:PMC10611265)

Tasker, S. et al. (2023) Feline infectious peritonitis: European Advisory Board on Cat Diseases Guideline. Viruses, 15(9), 1847. (doi: 10.3390/v15091847) (PMID:37766254) (PMCID:PMC10535984)

Hartmann, K. et al. (2023) Feline injection-site sarcoma and other adverse reactions to vaccination in cats. Viruses, 15(8), 1708. (doi: 10.3390/v15081708) (PMID:37632050) (PMCID:PMC10459272)

Jones, S. et al. (2023) SARS-CoV-2 in domestic UK cats from Alpha to Omicron: Swab surveillance and case reports. Viruses, 15(8), 1769. (doi: 10.3390/v15081769) (PMID:37632111) (PMCID:PMC10459977)

Tyson, G. B. et al. (2023) Increase in SARS-CoV-2 seroprevalence in UK domestic felids despite weak immunogenicity of post-Omicron variants. Viruses, 15(8), 1661. (doi: 10.3390/v15081661) (PMID:37632004) (PMCID:PMC10458763)

Tyson, G. B., Jones, S., Logan, N., McDonald, M., Marshall, L., Murcia, P. R. , Willett, B. J. , Weir, W. and Hosie, M. J. (2023) SARS-CoV-2 seroprevalence and cross-variant antibody neutralization in cats, United Kingdom. Emerging Infectious Diseases, 29(6), pp. 1223-1227. (doi: 10.3201/eid2906.221755) (PMID:37141617) (PMCID:PMC10202862)

Kuhlmeier, E. et al. (2023) Risk factor analysis of SARS-CoV-2 infection in animals in COVID-19-affected households. Viruses, 15(3), 731. (doi: 10.3390/v15030731) (PMID:36992440) (PMCID:PMC10051903)

Kuhlmeier, E. et al. (2023) Detection and molecular characterization of the SARS-CoV-2 Delta variant and the specific immune response in companion animals in Switzerland. Viruses, 15(1), 245. (doi: 10.3390/v15010245) (PMID:36680285) (PMCID:PMC9864232)

2022

Tyson, G. B., Jones, S., Logan, N., McDonald, M., Murcia, P. R. , Willett, B. J. , Weir, W. and Hosie, M. J. (2022) Rising SARS-CoV-2 seroprevalence and patterns of cross-variant antibody neutralization in UK domestic cats. bioRxiv, (doi: 10.1101/2022.11.18.517046)

Egberink, H. et al. (2022) Vaccination and antibody testing in cats. Viruses, 14(8), 1602. (doi: 10.3390/v14081602) (PMID:35893667) (PMCID:PMC9394466)

Hu, S., Logan, N., Coleman, S., Evans, C., Willett, B. J. and Hosie, M. J. (2022) Correlating IgG levels with neutralising antibody levels to indicate clinical protection in healthcare workers at risk during a measles outbreak. Viruses, 14(8), 1716. (doi: 10.3390/v14081716) (PMID:36016338) (PMCID:PMC9415042)

Hartmann, K. et al. (2022) Vaccination of immunocompromised cats. Viruses, 14(5), 923. (doi: 10.3390/v14050923) (PMID:35632665) (PMCID:PMC9147348)

Hofmann-Lehmann, R. et al. (2022) Calicivirus infection in cats. Viruses, 14(5), 937. (doi: 10.3390/v14050937) (PMID:35632680) (PMCID:PMC9145992)

Hu, S., Logan, N., Puenpa, J., Wanlapakorn, N., Vongpunsawad, S., Poovorawan, Y., Willett, B. J. and Hosie, M. J. (2022) Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants. Vaccine, 40(10), pp. 1439-1447. (doi: 10.1016/j.vaccine.2022.01.049) (PMID:35135700) (PMCID:PMC8884255)

Hosie, M. J. and Hofmann-Lehmann, R. (2022) Special issue: Viral infections in companion animals. Viruses, 14(2), 320. (doi: 10.3390/v14020320) (PMID:35215913) (PMCID:PMC8878503)

2021

Spiri, A. M., Novacco, M., Meli, M. L., Stirn, M., Riond, B., Fogle, J. E., Boretti, F. S., Herbert, I., Hosie, M. J. and Hofmann-Lehmann, R. (2021) Modified-live feline calicivirus vaccination elicits cellular immunity against a current feline calicivirus field strain in an experimental geline challenge study. Viruses, 13(9), 1736. (doi: 10.3390/v13091736)

Frymus, T. et al. (2021) Influenza virus infections in cats. Viruses, 13(8), 1435. (doi: 10.3390/v13081435)

Spiri, A. M., Riond, B., Stirn, M., Novacco, M., Meli, M. L., Boretti, F. S., Herbert, I., Hosie, M. J. and Hofmann-Lehmann, R. (2021) Modified-live feline calicivirus vaccination reduces viral RNA loads, duration of RNAemia, and the severity of clinical signs after heterologous feline calicivirus challenge. Viruses, 13(8), 1505. (doi: 10.3390/v13081505)

Hosie, M. J. et al. (2021) Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission. Veterinary Record, 188(8), e247. (doi: 10.1002/vetr.247) (PMID:33890314) (PMCID:PMC8251078)

Westman, M., Yang, D., Green, J., Norris, J., Malik, R., Parr, Y. A., McDonald, M., Hosie, M. J. , VandeWoude, S. and Miller, C. (2021) Antibody responses in cats following primary and annual vaccination against Feline Immunodeficiency Virus (FIV) with an inactivated whole-virus vaccine (Fel-O-Vax® FIV). Viruses, 13(3), 470. (doi: 10.3390/v13030470) (PMID:33809232) (PMCID:PMC7998844)

Parr, Y. A., Beall, M. J., Levy, J. K., McDonald, M. , Hamman, N. T., Willett, B. J. and Hosie, M. J. (2021) Measuring the humoral immune response in cats exposed to feline leukaemia virus. Viruses, 13(3), 428. (doi: 10.3390/v13030428) (PMID:33800090) (PMCID:PMC7998633)

Westman, M., Norris, J., Malik, R., Hofmann-Lehmann, R., Parr, Y. A., Armstrong, E., McDonald, M. , Hall, E., Sheehy, P. and Hosie, M. J. (2021) Anti-SU antibody responses in client-owned cats following vaccination against feline leukaemia virus with two inactivated whole-virus vaccines (Fel-O-Vax® Lv-K and Fel-O-Vax® 5). Viruses, 13(2), 240. (doi: 10.3390/v13020240) (PMID:33546485) (PMCID:PMC7913631)

Hosie, M. J. et al. (2021) Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic. Viruses, 13(2), 185. (doi: 10.3390/v13020185) (PMID:33530620) (PMCID:PMC7911697)

2020

Gilbert, M. et al. (2020) Distemper, extinction and vaccination of the Amur tiger. Proceedings of the National Academy of Sciences of the United States of America, 117(50), pp. 31954-31962. (doi: 10.1073/pnas.2000153117) (PMID:33229566) (PMCID:PMC7749280)

Murcia, P. , Streiker, D. , Da Silva Filipe, A. , Robertson, D. , Jarrett, R. , Willett, B. , Hosie, M. , Biek, R. , Allan, K. and Weir, W. (2020) Send cat and dog samples to test for SARS-CoV-2. Veterinary Record, 186(17), p. 571. (doi: 10.1136/vr.m2019) (PMID:32451348)

Little, S., Levy, J., Hartmann, K., Hofmann-Lehmann, R., Hosie, M. , Olah, G. and Denis, K. S. (2020) 2020 AAFP feline retrovirus testing and management guidelines. Journal of Feline Medicine and Surgery, 22(1), pp. 5-30. (doi: 10.1177/1098612X19895940) (PMID:31916872)

Hosie, M. and Jasim, S. (2020) The case for adopting a combined comparative medicine and One Health approach to tackle emerging diseases. Veterinary Record, 187(1), pp. 24-26. (doi: 10.1136/vr.m2686) (PMID:33638551) (PMCID:PMC7456687)

2019

Studer, N. et al. (2019) Pan-European study on the prevalence of the Feline Leukaemia Virus infection – Reported by the European Advisory Board on Cat Diseases (ABCD Europe). Viruses, 11(11), e993. (doi: 10.3390/v11110993) (PMID:31671816)

Noad, R. J. et al. (2019) UK vaccines network: mapping priority pathogens of epidemic potential and vaccine pipeline developments. Vaccine, 37(43), pp. 6241-6247. (doi: 10.1016/j.vaccine.2019.09.009) (PMID:31522809) (PMCID:PMC7127063)

Spiri, A. M., Meli, M. L., Riond, B., Herbert, I., Hosie, M. J. and Hofmann-Lehmann, R. (2019) Environmental contamination and hygienic measures after feline calicivirus field strain infections of cats in a research facility. Viruses, 11(10), 958. (doi: 10.3390/v11100958)

Teixeira, B. M. et al. (2019) Feline immunodeficiency virus in Northern Ceará, Brazil. Journal of Feline Medicine and Surgery Open Reports, 5(2), 2055116919. (doi: 10.1177/2055116919859112) (PMID:31312511) (PMCID:PMC6616103)

Westman, M. et al. (2019) The diagnosis of feline leukaemia virus (FeLV) infection in owned and group-housed rescue cats in Australia. Viruses, 11(6), 503. (doi: 10.3390/v11060503) (PMID:31159230) (PMCID:PMC6630418)

2018

Abdullah, N. et al. (2018) Structure-guided identification of a non-human morbillivirus with zoonotic potential. Journal of Virology, 92(23), e01248-18. (doi: 10.1128/JVI.01248-18) (PMID:30232185) (PMCID:PMC6232486)

Tasker, S. et al. (2018) Haemoplasmosis in cats: European guidelines from the ABCD on prevention and management. Journal of Feline Medicine and Surgery, 20(3), pp. 256-261. (doi: 10.1177/1098612X18758594) (PMID:29478400)

2017

Westman, M. E., Malik, R., Hall, E., Harris, M., Hosie, M. J. and Norris, J. M. (2017) Duration of antibody response following vaccination against feline immunodeficiency virus. Journal of Feline Medicine and Surgery, 19(10), pp. 1055-1064. (doi: 10.1177/1098612X16673292) (PMID:27770018)

Pennisi, M. G. et al. (2017) Anaplasma, Ehrlichia and Rickettsia species infections in cats: European guidelines from the ABCD on prevention and management. Journal of Feline Medicine and Surgery, 19(5), pp. 542-548. (doi: 10.1177/1098612X17706462) (PMID:28438088)

Hosie, M. J. , Techakriengkrai, N., Beczkowski, P. M., Harris, M., Logan, N. and Willett, B. (2017) The comparative value of feline virology research: can findings from the feline lentiviral vaccine be translated to humans? Veterinary Sciences, 4(1), 7. (doi: 10.3390/vetsci4010007)

2016

Logan, N., Dundon, W. G., Diallo, A., Baron, M. D., Nyarobi, M. J., Cleaveland, S. , Keyyu, J., Fyumagwa, R., Hosie, M. J. and Willett, B. J. (2016) Enhanced immunosurveillance for animal morbilliviruses using vesicular stomatitis virus (VSV) pseudotypes. Vaccine, 34(47), pp. 5736-5743. (doi: 10.1016/j.vaccine.2016.10.010) (PMID:27742221) (PMCID:PMC5084683)

Wensman, J. J., Samman, A., Lindhe, A., Thibault, J.-C., Berndtsson, L. T. and Hosie, M. (2016) Erratum to: Ability of vaccine strain induced antibodies to neutralize field isolates of caliciviruses from Swedish cats. Acta Veterinaria Scandinavica, 58(1), p. 14. (doi: 10.1186/s13028-016-0194-7) (PMID:26888695) (PMCID:PMC4758149)

Logan, N. et al. (2016) Efficient generation of vesicular stomatitis 1 virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies. Vaccine, 34(6), pp. 814-822. (doi: 10.1016/j.vaccine.2015.12.006) (PMID:6706278)

Willi, B. et al. (2016) Molecular characterization and virus neutralization patterns of severe, non-epizootic forms of feline calicivirus infections resembling virulent systemic disease in cats in Switzerland and in Liechtenstein. Veterinary Microbiology, 182, pp. 202-212. (doi: 10.1016/j.vetmic.2015.10.015) (PMID:26711049)

2015

Wensman, J. J., Samman, A., Lindhe, A., Thibault, J.-C., Berndtsson, L. T. and Hosie, M. (2015) Ability of vaccine strain induced antibodies to neutralize field isolates of caliciviruses from Swedish cats. Acta Veterinaria Scandinavica, 57(1), 86. (doi: 10.1186/s13028-015-0178-z) (PMID:26655039) (PMCID:PMC4676829)

Brennan, B. et al. (2015) In memoriam – Richard M. Elliott (1954–2015). Journal of General Virology, 96(8), pp. 1975-1978. (doi: 10.1099/jgv.0.000241) (PMID:26315040)

Addie, D. D. et al. (2015) Disinfectant choices in veterinary practices, shelters and households: ABCD guidelines on safe and effective disinfection for feline environments. Journal of Feline Medicine and Surgery, 17(7), pp. 594-605. (doi: 10.1177/1098612X15588450) (PMID:26101311)

Egberink, H. et al. (2015) West Nile virus infection in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 617-619. (doi: 10.1177/1098612X15588453) (PMID:26101314)

Frymus, T. et al. (2015) Streptococcal infections in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 620-625. (doi: 10.1177/1098612X15588454) (PMID:26101315)

Hartmann, K. et al. (2015) Feline injection-site sarcoma: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 606-613. (doi: 10.1177/1098612X15588451) (PMID:26101312)

Hosie, M. J. et al. (2015) Matrix vaccination guidelines: 2015 ABCD recommendations for indoor/outdoor cats, rescue shelter cats and breeding catteries. Journal of Feline Medicine and Surgery, 17(7), pp. 583-587. (doi: 10.1177/1098612X15590732) (PMID:26101309)

Lloret, A. et al. (2015) Cytauxzoonosis in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 637-641. (doi: 10.1177/1098612X15589878) (PMID:26101317)

Lloret, A. et al. (2015) Hepatozoonosis in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 642-644. (doi: 10.1177/1098612X15589879) (PMID:26101318)

Lutz, H. et al. (2015) Borna disease virus infection in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 614-616. (doi: 10.1177/1098612X15588452) (PMID:26101313)

Mostl, K. et al. (2015) Something old, something new: update of the 2009 and 2013 ABCD guidelines on prevention and management of feline infectious diseases. Journal of Feline Medicine and Surgery, 17(7), pp. 570-582. (doi: 10.1177/1098612X15588448) (PMID:26101308)

Pennisi, M. G. et al. (2015) Lungworm disease in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 626-636. (doi: 10.1177/1098612X15588455) (PMID:26101316)

Pennisi, M. G. et al. (2015) Blood transfusion in cats: ABCD guidelines for minimising risks of infectious iatrogenic complications. Journal of Feline Medicine and Surgery, 17(7), pp. 588-593. (doi: 10.1177/1098612X15588449) (PMID:26101310)

Lehmann, M., Weber, K., Rauch, G., Hofmann-Lehmann, R., Hosie, M. , Meli, M. and Hartmann, K. (2015) Efficacy of siRNA on feline leukemia virus replication in vitro. Berliner und Munchener Tierarztliche Wochenschrift, 128(56), pp. 209-217. (doi: 10.2376/0005-0366-128-200)

Beczkowski, P. M., Hughes, J. , Biek, R. , Litster, A., Willett, B. J. and Hosie, M. J. (2015) Rapid evolution of the env gene leader sequence in cats naturally infected with feline immunodeficiency virus (FIV). Journal of General Virology, 96(4), pp. 893-903. (doi: 10.1099/vir.0.000035) (PMID:25535323) (PMCID:PMC4361796)

Beczkowski, P., Logan, N., McMonagle, E., Litster, A., Willett, B. J. and Hosie, M. J. (2015) An investigation of the breadth of neutralising antibody response in cats naturally infected with feline immunodeficiency virus. Journal of General Virology, 96(3), pp. 671-680. (doi: 10.1099/vir.0.071522-0) (PMID:25395594) (PMCID:PMC4336861)

Bęczkowski, P. M., Litster, A., Lin, T. L., Mellor, D. J. , Willett, B. J. and Hosie, M. J. (2015) Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV). Veterinary Microbiology, 176(1-2), pp. 50-60. (doi: 10.1016/j.vetmic.2014.12.023) (PMID:25595267) (PMCID:PMC4332694)

Boesch, A., Cattori, V., Riond, B., Willi, B., Meli, M. L., Rentsch, K. M., Hosie, M. J. , Hofmann-Lehmann, R. and Lutz, H. (2015) Evaluation of the effect of short-term treatment with the integrase inhibitor raltegravir (Isentress™) on the course of progressive feline leukemia virus infection. Veterinary Microbiology, 175(2-4), pp. 167-178. (doi: 10.1016/j.vetmic.2014.10.031) (PMID:25500005)

Beczkowski, P. M., Harris, M., Techakriengkrai, N., Beatty, J. A., Willett, B. J. and Hosie, M. J. (2015) Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine. Vaccine, 33(8), pp. 977-984. (doi: 10.1016/j.vaccine.2015.01.028) (PMID:25613718) (PMCID:PMC4327927)

2014

Beczkowski, P. M., Techakriengkrai, N., Logan, N., McMonagle, E., Litster, A., Willett, B. J. and Hosie, M. J. (2014) Emergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats. Retrovirology, 11, p. 95. (doi: 10.1186/s12977-014-0095-7) (PMID:25430586) (PMCID:PMC4275942)

Bęczkowski, P. M., Hughes, J. , Biek, R. , Litster, A., Willett, B. J. and Hosie, M. J. (2014) Feline immunodeficiency virus (FIV) env recombinants are common in natural infections. Retrovirology, 11(80), (doi: 10.1186/s12977-014-0080-1) (PMID:25699660) (PMCID:PMC4180853)

2013

Willett, B.J. and Hosie, M.J. (2013) The virus–receptor interaction in the replication of feline immunodeficiency virus (FIV). Current Opinion in Virology, 3(6), pp. 670-675. (doi: 10.1016/j.coviro.2013.08.003)

Chan, C.N., Dietrich, I., Hosie, M.J. and Willett, B.J. (2013) Recent developments in human immunodeficiency virus-1 latency research. Journal of General Virology, 94(5), pp. 917-932. (doi: 10.1099/vir.0.049296-0)

Chan, C.N., McMonagle, E.L., Hosie, M.J. and Willett, B.J. (2013) Prostratin exhibits both replication enhancing and inhibiting effects on FIV infection of feline CD4+ T-cells. Virus Research, 171(1), pp. 121-128. (doi: 10.1016/j.virusres.2012.11.004)

Stewart, H., Jarrett, O., Hosie, M.J. and Willett, B.J. (2013) Complete genome sequences of two feline Leukemia virus subgroup B isolates with novel recombination sites. Genome Announcements, 1(1), e00036-12. (doi: 10.1128/genomeA.00036-12)

Willett, B.J. and Hosie, M.J. (2013) Feline leukaemia virus: half a century since its discovery. Veterinary Journal, 195(1), pp. 16-23. (doi: 10.1016/j.tvjl.2012.07.004)

Willett, B.J. , Kraase, M., Logan, N., McMonagle, E., Varela, M. and Hosie, M.J. (2013) Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispecies. PLoS ONE, 8(1), e54871. (doi: 10.1371/journal.pone.0054871) (PMID:23372784) (PMCID:PMC3553009)

2012

Stewart, H., Adema, K. W., McMonagle, E. L., Hosie, M. J. and Willett, B. J. (2012) Identification of novel subgroup a variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus. Retrovirology, 9, 48. (doi: 10.1186/1742-4690-9-48) (PMID:22650160) (PMCID:PMC3403869)

Teixeira, B.M., Hagiwara, M.K., Cruz, J.C.M. and Hosie, M.J. (2012) Feline immunodeficiency virus in South America. Viruses, 4(3), pp. 383-396. (doi: 10.3390/v4030383)

2011

Dietrich, I., Hosie, M. J. and Willett, B. J. (2011) The role of BST2/tetherin in feline retrovirus infection. Veterinary Immunology and Immunopathology, 143(3-4), pp. 255-264. (doi: 10.1016/j.vetimm.2011.06.020)

Dietrich, I., McEwan, W. A., Hosie, M. J. and Willett, B. J. (2011) Restriction of the felid lentiviruses by a synthetic feline TRIM5-CypA fusion. Veterinary Immunology and Immunopathology, 143(3-4), pp. 235-242. (doi: 10.1016/j.vetimm.2011.06.017)

Stewart, H., Jarrett, O., Hosie, M.J. and Willett, B.J. (2011) Are endogenous feline leukemia viruses really endogenous? Veterinary Immunology and Immunopathology, 143(3-4), pp. 325-331. (doi: 10.1016/j.vetimm.2011.06.011)

Hosie, M. J. , Pajek, D., Samman, A. and Willett, B. J. (2011) Feline immunodeficiency virus (FIV) neutralization: a review. Viruses, 3(10), pp. 1870-1890. (doi: 10.3390/v3101870)

Teixeira, B.M., Logan, N., Samman, A., Miyashiro, S.I., Brandão, P.E., Willett, B.J. , Hosie, M.J. and Hagiwara, M.K. (2011) Isolation and partial characterization of Brazilian samples of feline immunodeficiency virus. Virus Research, 160(1-2), pp. 59-65. (doi: 10.1016/j.virusres.2011.05.007)

Dietrich, I., McMonagle, E. L., Petit, S. J., Vijayakrishnan, S. , Logan, N., Chan, C. N., Towers, G. J., Hosie, M. J. and Willett, B. J. (2011) Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection. Journal of Virology, 85(12), pp. 5840-5852. (doi: 10.1128/JVI.00071-11) (PMID:21490095) (PMCID:PMC3126296)

Samman, A., McMonagle, E.L., Logan, N., Willett, B.J. , Biek, R. and Hosie, M.J. (2011) Phylogenetic characterisation of naturally occurring feline immunodeficiency virus in the United Kingdom. Veterinary Microbiology, 150(3-4), pp. 239-247. (doi: 10.1016/j.vetmic.2011.01.027)

2010

Dietrich, I., MacIntyre, A., McMonagle, E., Price, A.J., James, L.C., McEwan, W.A., Hosie, M.J. and Willett, B.J. (2010) Potent lentiviral restriction by a synthetic feline TRIM5 cyclophilin A fusion. Journal of Virology, 84(17), pp. 8980-8985. (doi: 10.1128/JVI.00858-10)

Willett, B. J., Kraase, M., Logan, N., McMonagle, E. L., Samman, A. and Hosie, M. J. (2010) Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody. Retrovirology, 7(1), p. 38. (doi: 10.1186/1742-4690-7-38) (PMID:20420700) (PMCID:PMC2873508)

Kraase, M., Sloan, R., Klein, D., Logan, N., McMonagle, L., Biek, R. , Willett, B. J. and Hosie, M. J. (2010) Feline immunodeficiency virus env gene evolution in experimentally infected cats. Veterinary Immunology and Immunopathology, 134(1-2), pp. 96-106. (doi: 10.1016/j.vetimm.2009.10.015) (PMID:19897254)

Teixeira, B. M., Logan, N., Cruz, J.C.M., Reis, J.K.P., Brandão, P.E., Richtzenhain, L.J., Hagiwara, M.K., Willett, B.J. and Hosie, M.J. (2010) Genetic diversity of Brazilian isolates of feline immunodeficiency virus. Archives of Virology, 155(3), pp. 379-384. (doi: 10.1007/s00705-009-0587-2)

Samman, A., Logan, N., McMonagle, E. L., Ishida, T., Mochizuki, M., Willett, B. J. and Hosie, M. J. (2010) Neutralization of feline immunodeficiency virus by antibodies targeting the V5 loop of Env. Journal of General Virology, 91(1), pp. 242-249. (doi: 10.1099/vir.0.015404-0)

Willett, B.J. and Hosie, M.J. (2010) The felid immunodeficiency viruses: viral cell tropism and the pathogenesis of feline AIDS. In: Desport, M. (ed.) Lentiviruses and Macrophages. Horizon Scientific Press. ISBN 9781904455608

2009

Fletcher, N.F., Bexiga, M.G., Brayden, D.J., Brankin, B., Willett, B.J., Hosie, M.J., Jacque, J.M. and Callanan, J.J. (2009) Lymphocyte migration through the blood brain barrier (BBB) in feline immunodeficiency virus infection is significantly influenced by the pre-existence of virus and TNF-α within the CNS: studies using an in vitro feline BBB model. Neuropathology and Applied Neurobiology, 35(6), pp. 592-602. (doi: 10.1111/j.1365-2990.2009.01031.x)

McEwan, W. A., Schaller, T., Ylinen, L. M., Hosie, M. J., Towers, G. J. and Willett, B. J. (2009) Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat. Journal of Virology, 83(16), pp. 8270-8275. (doi: 10.1128/JVI.00670-09) (PMID:19494015) (PMCID:PMC2715776)

Addie, D. et al. (2009) Feline infectious peritonitis. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 594-604. (doi: 10.1016/j.jfms.2009.05.008)

Egberink, H. et al. (2009) Bordetella bronchiseptica infection in cats. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 610-614. (doi: 10.1016/j.jfms.2009.05.010)

Frymus, T. et al. (2009) Feline rabies. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 585-593. (doi: 10.1016/j.jfms.2009.05.007)

Gruffydd-Jones, T. et al. (2009) Chlamydophila felis infection. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 605-609. (doi: 10.1016/j.jfms.2009.05.009)

Hosie, M. J. et al. (2009) Feline immunodeficiency. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 575-584. (doi: 10.1016/j.jfms.2009.05.006)

Lutz, H. et al. (2009) Feline leukaemia. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 565-574. (doi: 10.1016/j.jfms.2009.05.005)

Radford, A. D. et al. (2009) Feline calicivirus infection. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 556-564. (doi: 10.1016/j.jfms.2009.05.004)

Thiry, E. et al. (2009) H5N1 avian influenza in cats. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 615-618. (doi: 10.1016/j.jfms.2009.05.011)

Thiry, E. et al. (2009) Feline herpesvirus infection. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 547-555. (doi: 10.1016/j.jfms.2009.05.003)

Truyen, U. et al. (2009) Feline panleukopenia. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 538-546. (doi: 10.1016/j.jfms.2009.05.002)

Willett, B. J., McMonagle, E. L., Logan, N., Schneider, P. and Hosie, M. J. (2009) Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus. Molecular Immunology, 46(6), pp. 1020-1030. (doi: 10.1016/j.molimm.2008.08.271)

2008

McEwan, W. A., McMonagle, E. L., Logan, N., Serra, R. C., Kat, P., Vandewoude, S., Hosie, M. J. and Willett, B. J. (2008) Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors. Journal of Virology, 82(21), pp. 10953-10958. (doi: 10.1128/JVI.01312-08)

Addie, D., Poulet, H., Golder, M.C., McDonald, M. , Brunet, S., Thibault, J.-C. and Hosie, M.J. (2008) Ability of antibodies to two new caliciviral vaccine strains to neutralise feline calicivirus isolates from the UK. Veterinary Record, 163(12), pp. 355-7. (doi: 10.1136/vr.163.12.355)

Willett, B. J., McMonagle, E. L., Logan, N., Samman, A. and Hosie, M. J. (2008) A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction. Retrovirology, 5(77), (doi: 10.1186/1742-4690-5-77)

Willett, B. J. and Hosie, M. J. (2008) Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection. Veterinary Immunology and Immunopathology, 123(1-2), pp. 56-64. (doi: 10.1016/j.vetimm.2008.01.012)

Fletcher, N.F., Bexiga, M., Brayden, D.J., Brankin, B., Willett, B.J. , Hosie, M.J. , Jacque, J.M. and Callanan, J.J. (2008) Cell migration through the blood brain barrier (BBB) in feline immunodeficiency virus infection is significantly influenced by the pre-existence of virus and tnf-alpha within the CNS: studies using an in vitro feline BBB model. Journal of Neuroimmunology, 197(2), p. 161.

2007

Hosie, M. J. and Beatty, J. A. (2007) Vaccine protection against feline immunodeficiency virus: setting the challenge. Australian Veterinary Journal, 85(1-2), pp. 5-12. (doi: 10.1111/j.1751-0813.2006.00071.x)

Willett, B.J., McMonagle, E.L., Logan, N., Spiller, O.B., Schneider, P. and Hosie, M.J. (2007) Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligand. Journal of Virology, 81(18), pp. 9665-9679. (doi: 10.1128/JVI.01020-07)

2006

Willett, B.J., McMonagle, E.L., Bonci, F., Pistello, M. and Hosie, M.J. (2006) Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus (FIV). Journal of Virology, 80(15), pp. 7744-7747. (doi: 10.1128/JVI.00722-06)

Willett, B.J., McMonagle, E.L., Ridha, S. and Hosie, M.J. (2006) Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus. Journal of Virology, 80(7), pp. 3386-3394. (doi: 10.1128/JVI.80.7.3386-3394.2006)

Willett, B., McMonagle, E., Bonci, F., Pistello, M. and Hosie, M. (2006) Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus. Journal of Virology, 80, pp. 7744-7747. (doi: 10.1128/JVI.00722-06)

2005

Hosie, M.J. et al. (2005) Vaccination with an Inactivated Virulent Feline Immunodeficiency Virus Engineered to Express High Levels of Env. Journal of Virology, 79(3), pp. 1954-1957.

Ryan, G., Grimes, T., Brankin, B., Mabruk, M., Hosie, M., Jarrett, O. and Callanan, J. (2005) Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers. Journal of Neurovirology, 11, pp. 337-345. (doi: 10.1080/13550280500186445)

2004

Tebb, A.J., Cave, T., Barron, R., Brown, A.L., Martineau, H.M., Willett, B. and Hosie, M.J. (2004) Diagnosis and management of β cell chronic lymphocytic leukaemia in a cat. Veterinary Record, 154(14), pp. 430-433. (doi: 10.1136/vr.154.14.430)

Shimojima, M., Miyazawa, T., Ikeda, Y., McMonagle, E.L., Haining, H., Akashi, H., Takeuchi, Y., Hosie, M.J. and Willett, B.J. (2004) Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science, 303(20), pp. 1192-1195. (doi: 10.1126/science.1092124)

2003

Ryan, G., Klein, D., Knapp, E., Hosie, M., Grimes, T., Mabruk, M., Jarrett, O. and Callanan, J. (2003) Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection. Journal of Virology, 77, pp. 7477-7485. (doi: 10.1128/JVI.77.13.7477-7485.2003)

Willett, B.J., Cannon, C.A. and Hosie, M.J. (2003) Expression of CXCR4 on feline peripheral blood mononuclear cells: effect of feline immunodeficiency virus infection. Journal of Virology, 77(1), pp. 709-712. (doi: 10.1128/JVI.77.1.709-712.2003)

2002

Brown, A., Dunsford, T., Jarrett, O., Willett, B. and Hosie, M. (2002) Demonstration of biological activity of CD40 ligand (CD154) in the domestic cat. Cytokine, 17, pp. 140-148. (doi: 10.1006/cyto.2001.0993)

Hosie, M.J. , Willett, B.J. , Klein, D., Dunsford, T.H., Cannon, C., Shimojima, M., Neil, J.C. and Jarrett, O. (2002) Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. Journal of Virology, 76(12), pp. 6062-6072. (doi: 10.1128/JVI.76.12.6062-6072.2002)

2001

Lawson, M.H. and Hosie, M.J. (2001) Follow up of feline immunodeficiency virus-infected cats. Veterinary Record, 148(14), pp. 449-450. (doi: 10.1136/vr.148.14.449)

2000

Hosie, M.J. et al. (2000) Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. Journal of Virology, 74(20), pp. 9403-9411. (doi: 10.1128/JVI.74.20.9403-9411.2000)

Flynn, J.N., Hosie, M.J. , Rigby, M.A., Mackay, N., Cannon, C.A., Dunsford, T., Neil, J.C. and Jarrett, O. (2000) Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination. Vaccine, 18(11-12), pp. 1118-1132. (doi: 10.1016/S0264-410X(99)00375-8) (PMID:10590334)

1999

Willett, B.J. and Hosie, M.J. (1999) The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus. Molecular Membrane Biology, 16(1), pp. 67-72. (doi: 10.1080/096876899294779)

1998

Hosie, M.J. et al. (1998) DNA vaccination affords significant protection against feline immunodeficiency virus without inducing detectable antiviral antibodies. Journal of Virology, 72(9), pp. 7310-7319.

Willett, B.J. et al. (1998) The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. Journal of Virology, 72(8), pp. 6475-6481.

Hosie, M.J. , Broere, N., Hesselgesser, J., Turner, J.D., Hoxie, J.A., Neil, J.C. and Willett, B.J. (1998) Modulation of feline immunodeficiency virus infection by stromal cell-derived factor (SDF-1). Journal of Virology, 72(3), pp. 2097-2104.

1997

Rigby, M.A., Hosie, M.J., Willett, B.J., Mackay, N., McDonald, M., Cannon, C., Dunsford, T., Jarrett, O. and Neil, J.C. (1997) Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation. AIDS Research and Human Retroviruses, 13(5), pp. 405-12. (doi: 10.1089/aid.1997.13.405) (PMID:9075482)

Willett, B. , Hosie, M. , Shaw, A. and Neil, J.C. (1997) Inhibition of feline immunodeficiency virus infection by CD9 antibody operates after virus entry and is independent of virus tropism. Journal of General Virology, 78(3), pp. 611-618. (doi: 10.1099/0022-1317-78-3-611)

Willett, B.J., Flynn, J.N. and Hosie, M.J. (1997) FIV infection of the domestic cat: an animal model for AIDS. Immunology Today, 18(4), pp. 182-9.

Willett, B.J., Hosie, M.J. , Neil, J.C. , Turner, J.D. and Hoxie, J.A. (1997) Common mechanism of infection by lentiviruses. Nature, 385(6617), p. 587. (doi: 10.1038/385587a0)

1996

Flynn, J.N., Keating, P., Hosie, M.J. , Mackett, M., Stephens, E.B., Beatty, J.A., Neil, J.C. and Jarrett, O. (1996) Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. Journal of Immunology, 157(8), pp. 3658-65. (PMID:8871667)

Hosie, M.J., Dunsford, T.H., de Ronde, A., Willett, B.J., Cannon, C.A., Neil, J.C. and Jarrett, O. (1996) Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine, 14(5), pp. 405-411. (doi: 10.1016/0264-410X(95)00193-5)

1995

Hosie, M.J. , Osborne, R., Yamamoto, J.K., Neil, J.C. and Jarrett, O. (1995) Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. Journal of Virology, 69(2), pp. 1253-1255.

Flynn, J.N., Beatty, J.A., Cannon, C.A., Stephens, E.B., Hosie, M.J. , Neil, J.C. and Jarrett, O. (1995) Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Research and Human Retroviruses, 11(9), pp. 1107-1113. (doi: 10.1089/aid.1995.11.1107) (PMID:8554908)

Neil, J.C. et al. (1995) Development of AIDS vaccine strategies in a feline animal model. AIDS Research and Human Retroviruses, 11, S136.

1994

Willett, B.J. , Hosie, M.J. , Jarrett, O. and Neil, J.C. (1994) Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology, 81(2), pp. 228-33. (PMID:8157271)

1993

Hosie, M.J. , Willett, B.J. , Dunsford, T.H., Jarrett, O. and Neil, J.C. (1993) A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. Journal of Virology, 67(3), pp. 1667-1671. (PMID:7679750) (PMCID:PMC237540)

Willett, B.J. , Hosie, M. , Neil, J.C. and Jarrett, O. (1993) Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology, 78, pp. 1-6. (PMCID:PMC1421779)

1992

Hosie, M. J. , Osborne, R., Reid, G., Neil, J. C. and Jarrett, O. (1992) Enhancement after feline immunodeficiency virus vaccination. Veterinary Immunology and Immunopathology, 35(1-2), pp. 191-197. (doi: 10.1016/0165-2427(92)90131-9) (PMID:1337397)

1991

Willett, B.J. , Hosie, M.J. , Dunsford, T.H., Neil, J.C. and Jarrett, O. (1991) Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS, 5(12), pp. 1469-75. (PMID:1687647)

This list was generated on Mon Nov 18 23:04:56 2024 GMT.
Jump to: Articles | Book Sections | Conference or Workshop Item
Number of items: 140.

Articles

Kuhn, J. et al. (2024) Investigations on the potential role of free-ranging wildlife as a reservoir of SARS-CoV-2 in Switzerland. Viruses, 16(9), 1407. (doi: 10.3390/v16091407)

Dunbar, D., Babayan, S. A. , Krumrie, S. , Haining, H., Hosie, M. J. and Weir, W. (2024) Assessing the feasibility of applying machine learning to diagnosing non-effusive feline infectious peritonitis. Scientific Reports, 14, 2517. (doi: 10.1038/s41598-024-52577-4) (PMID:38291072)

Hüttl, J. et al. (2024) Serological and molecular investigation of SARS-CoV-2 in horses and cattle in Switzerland from 2020 to 2022. Viruses, 16(2), 224. (doi: 10.3390/v16020224)

Willett, B. J. et al. (2023) Omicron BA.2.86 cross-neutralising activity in community sera from the UK. Lancet, 402(10417), pp. 2075-2076. (doi: 10.1016/s0140-6736(23)02397-8) (PMID:37952549)

Pennisi, M. G. et al. (2023) Feline morbillivirus: clinical relevance of a widespread endemic viral infection of cats. Viruses, 15(10), 2087. (doi: 10.3390/v15102087) (PMID:37896864) (PMCID:PMC10611265)

Tasker, S. et al. (2023) Feline infectious peritonitis: European Advisory Board on Cat Diseases Guideline. Viruses, 15(9), 1847. (doi: 10.3390/v15091847) (PMID:37766254) (PMCID:PMC10535984)

Hartmann, K. et al. (2023) Feline injection-site sarcoma and other adverse reactions to vaccination in cats. Viruses, 15(8), 1708. (doi: 10.3390/v15081708) (PMID:37632050) (PMCID:PMC10459272)

Jones, S. et al. (2023) SARS-CoV-2 in domestic UK cats from Alpha to Omicron: Swab surveillance and case reports. Viruses, 15(8), 1769. (doi: 10.3390/v15081769) (PMID:37632111) (PMCID:PMC10459977)

Tyson, G. B. et al. (2023) Increase in SARS-CoV-2 seroprevalence in UK domestic felids despite weak immunogenicity of post-Omicron variants. Viruses, 15(8), 1661. (doi: 10.3390/v15081661) (PMID:37632004) (PMCID:PMC10458763)

Tyson, G. B., Jones, S., Logan, N., McDonald, M., Marshall, L., Murcia, P. R. , Willett, B. J. , Weir, W. and Hosie, M. J. (2023) SARS-CoV-2 seroprevalence and cross-variant antibody neutralization in cats, United Kingdom. Emerging Infectious Diseases, 29(6), pp. 1223-1227. (doi: 10.3201/eid2906.221755) (PMID:37141617) (PMCID:PMC10202862)

Kuhlmeier, E. et al. (2023) Risk factor analysis of SARS-CoV-2 infection in animals in COVID-19-affected households. Viruses, 15(3), 731. (doi: 10.3390/v15030731) (PMID:36992440) (PMCID:PMC10051903)

Kuhlmeier, E. et al. (2023) Detection and molecular characterization of the SARS-CoV-2 Delta variant and the specific immune response in companion animals in Switzerland. Viruses, 15(1), 245. (doi: 10.3390/v15010245) (PMID:36680285) (PMCID:PMC9864232)

Tyson, G. B., Jones, S., Logan, N., McDonald, M., Murcia, P. R. , Willett, B. J. , Weir, W. and Hosie, M. J. (2022) Rising SARS-CoV-2 seroprevalence and patterns of cross-variant antibody neutralization in UK domestic cats. bioRxiv, (doi: 10.1101/2022.11.18.517046)

Egberink, H. et al. (2022) Vaccination and antibody testing in cats. Viruses, 14(8), 1602. (doi: 10.3390/v14081602) (PMID:35893667) (PMCID:PMC9394466)

Hu, S., Logan, N., Coleman, S., Evans, C., Willett, B. J. and Hosie, M. J. (2022) Correlating IgG levels with neutralising antibody levels to indicate clinical protection in healthcare workers at risk during a measles outbreak. Viruses, 14(8), 1716. (doi: 10.3390/v14081716) (PMID:36016338) (PMCID:PMC9415042)

Hartmann, K. et al. (2022) Vaccination of immunocompromised cats. Viruses, 14(5), 923. (doi: 10.3390/v14050923) (PMID:35632665) (PMCID:PMC9147348)

Hofmann-Lehmann, R. et al. (2022) Calicivirus infection in cats. Viruses, 14(5), 937. (doi: 10.3390/v14050937) (PMID:35632680) (PMCID:PMC9145992)

Hu, S., Logan, N., Puenpa, J., Wanlapakorn, N., Vongpunsawad, S., Poovorawan, Y., Willett, B. J. and Hosie, M. J. (2022) Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants. Vaccine, 40(10), pp. 1439-1447. (doi: 10.1016/j.vaccine.2022.01.049) (PMID:35135700) (PMCID:PMC8884255)

Hosie, M. J. and Hofmann-Lehmann, R. (2022) Special issue: Viral infections in companion animals. Viruses, 14(2), 320. (doi: 10.3390/v14020320) (PMID:35215913) (PMCID:PMC8878503)

Spiri, A. M., Novacco, M., Meli, M. L., Stirn, M., Riond, B., Fogle, J. E., Boretti, F. S., Herbert, I., Hosie, M. J. and Hofmann-Lehmann, R. (2021) Modified-live feline calicivirus vaccination elicits cellular immunity against a current feline calicivirus field strain in an experimental geline challenge study. Viruses, 13(9), 1736. (doi: 10.3390/v13091736)

Frymus, T. et al. (2021) Influenza virus infections in cats. Viruses, 13(8), 1435. (doi: 10.3390/v13081435)

Spiri, A. M., Riond, B., Stirn, M., Novacco, M., Meli, M. L., Boretti, F. S., Herbert, I., Hosie, M. J. and Hofmann-Lehmann, R. (2021) Modified-live feline calicivirus vaccination reduces viral RNA loads, duration of RNAemia, and the severity of clinical signs after heterologous feline calicivirus challenge. Viruses, 13(8), 1505. (doi: 10.3390/v13081505)

Hosie, M. J. et al. (2021) Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission. Veterinary Record, 188(8), e247. (doi: 10.1002/vetr.247) (PMID:33890314) (PMCID:PMC8251078)

Westman, M., Yang, D., Green, J., Norris, J., Malik, R., Parr, Y. A., McDonald, M., Hosie, M. J. , VandeWoude, S. and Miller, C. (2021) Antibody responses in cats following primary and annual vaccination against Feline Immunodeficiency Virus (FIV) with an inactivated whole-virus vaccine (Fel-O-Vax® FIV). Viruses, 13(3), 470. (doi: 10.3390/v13030470) (PMID:33809232) (PMCID:PMC7998844)

Parr, Y. A., Beall, M. J., Levy, J. K., McDonald, M. , Hamman, N. T., Willett, B. J. and Hosie, M. J. (2021) Measuring the humoral immune response in cats exposed to feline leukaemia virus. Viruses, 13(3), 428. (doi: 10.3390/v13030428) (PMID:33800090) (PMCID:PMC7998633)

Westman, M., Norris, J., Malik, R., Hofmann-Lehmann, R., Parr, Y. A., Armstrong, E., McDonald, M. , Hall, E., Sheehy, P. and Hosie, M. J. (2021) Anti-SU antibody responses in client-owned cats following vaccination against feline leukaemia virus with two inactivated whole-virus vaccines (Fel-O-Vax® Lv-K and Fel-O-Vax® 5). Viruses, 13(2), 240. (doi: 10.3390/v13020240) (PMID:33546485) (PMCID:PMC7913631)

Hosie, M. J. et al. (2021) Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic. Viruses, 13(2), 185. (doi: 10.3390/v13020185) (PMID:33530620) (PMCID:PMC7911697)

Gilbert, M. et al. (2020) Distemper, extinction and vaccination of the Amur tiger. Proceedings of the National Academy of Sciences of the United States of America, 117(50), pp. 31954-31962. (doi: 10.1073/pnas.2000153117) (PMID:33229566) (PMCID:PMC7749280)

Murcia, P. , Streiker, D. , Da Silva Filipe, A. , Robertson, D. , Jarrett, R. , Willett, B. , Hosie, M. , Biek, R. , Allan, K. and Weir, W. (2020) Send cat and dog samples to test for SARS-CoV-2. Veterinary Record, 186(17), p. 571. (doi: 10.1136/vr.m2019) (PMID:32451348)

Little, S., Levy, J., Hartmann, K., Hofmann-Lehmann, R., Hosie, M. , Olah, G. and Denis, K. S. (2020) 2020 AAFP feline retrovirus testing and management guidelines. Journal of Feline Medicine and Surgery, 22(1), pp. 5-30. (doi: 10.1177/1098612X19895940) (PMID:31916872)

Hosie, M. and Jasim, S. (2020) The case for adopting a combined comparative medicine and One Health approach to tackle emerging diseases. Veterinary Record, 187(1), pp. 24-26. (doi: 10.1136/vr.m2686) (PMID:33638551) (PMCID:PMC7456687)

Studer, N. et al. (2019) Pan-European study on the prevalence of the Feline Leukaemia Virus infection – Reported by the European Advisory Board on Cat Diseases (ABCD Europe). Viruses, 11(11), e993. (doi: 10.3390/v11110993) (PMID:31671816)

Noad, R. J. et al. (2019) UK vaccines network: mapping priority pathogens of epidemic potential and vaccine pipeline developments. Vaccine, 37(43), pp. 6241-6247. (doi: 10.1016/j.vaccine.2019.09.009) (PMID:31522809) (PMCID:PMC7127063)

Spiri, A. M., Meli, M. L., Riond, B., Herbert, I., Hosie, M. J. and Hofmann-Lehmann, R. (2019) Environmental contamination and hygienic measures after feline calicivirus field strain infections of cats in a research facility. Viruses, 11(10), 958. (doi: 10.3390/v11100958)

Teixeira, B. M. et al. (2019) Feline immunodeficiency virus in Northern Ceará, Brazil. Journal of Feline Medicine and Surgery Open Reports, 5(2), 2055116919. (doi: 10.1177/2055116919859112) (PMID:31312511) (PMCID:PMC6616103)

Westman, M. et al. (2019) The diagnosis of feline leukaemia virus (FeLV) infection in owned and group-housed rescue cats in Australia. Viruses, 11(6), 503. (doi: 10.3390/v11060503) (PMID:31159230) (PMCID:PMC6630418)

Abdullah, N. et al. (2018) Structure-guided identification of a non-human morbillivirus with zoonotic potential. Journal of Virology, 92(23), e01248-18. (doi: 10.1128/JVI.01248-18) (PMID:30232185) (PMCID:PMC6232486)

Tasker, S. et al. (2018) Haemoplasmosis in cats: European guidelines from the ABCD on prevention and management. Journal of Feline Medicine and Surgery, 20(3), pp. 256-261. (doi: 10.1177/1098612X18758594) (PMID:29478400)

Westman, M. E., Malik, R., Hall, E., Harris, M., Hosie, M. J. and Norris, J. M. (2017) Duration of antibody response following vaccination against feline immunodeficiency virus. Journal of Feline Medicine and Surgery, 19(10), pp. 1055-1064. (doi: 10.1177/1098612X16673292) (PMID:27770018)

Pennisi, M. G. et al. (2017) Anaplasma, Ehrlichia and Rickettsia species infections in cats: European guidelines from the ABCD on prevention and management. Journal of Feline Medicine and Surgery, 19(5), pp. 542-548. (doi: 10.1177/1098612X17706462) (PMID:28438088)

Hosie, M. J. , Techakriengkrai, N., Beczkowski, P. M., Harris, M., Logan, N. and Willett, B. (2017) The comparative value of feline virology research: can findings from the feline lentiviral vaccine be translated to humans? Veterinary Sciences, 4(1), 7. (doi: 10.3390/vetsci4010007)

Logan, N., Dundon, W. G., Diallo, A., Baron, M. D., Nyarobi, M. J., Cleaveland, S. , Keyyu, J., Fyumagwa, R., Hosie, M. J. and Willett, B. J. (2016) Enhanced immunosurveillance for animal morbilliviruses using vesicular stomatitis virus (VSV) pseudotypes. Vaccine, 34(47), pp. 5736-5743. (doi: 10.1016/j.vaccine.2016.10.010) (PMID:27742221) (PMCID:PMC5084683)

Wensman, J. J., Samman, A., Lindhe, A., Thibault, J.-C., Berndtsson, L. T. and Hosie, M. (2016) Erratum to: Ability of vaccine strain induced antibodies to neutralize field isolates of caliciviruses from Swedish cats. Acta Veterinaria Scandinavica, 58(1), p. 14. (doi: 10.1186/s13028-016-0194-7) (PMID:26888695) (PMCID:PMC4758149)

Logan, N. et al. (2016) Efficient generation of vesicular stomatitis 1 virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies. Vaccine, 34(6), pp. 814-822. (doi: 10.1016/j.vaccine.2015.12.006) (PMID:6706278)

Willi, B. et al. (2016) Molecular characterization and virus neutralization patterns of severe, non-epizootic forms of feline calicivirus infections resembling virulent systemic disease in cats in Switzerland and in Liechtenstein. Veterinary Microbiology, 182, pp. 202-212. (doi: 10.1016/j.vetmic.2015.10.015) (PMID:26711049)

Wensman, J. J., Samman, A., Lindhe, A., Thibault, J.-C., Berndtsson, L. T. and Hosie, M. (2015) Ability of vaccine strain induced antibodies to neutralize field isolates of caliciviruses from Swedish cats. Acta Veterinaria Scandinavica, 57(1), 86. (doi: 10.1186/s13028-015-0178-z) (PMID:26655039) (PMCID:PMC4676829)

Brennan, B. et al. (2015) In memoriam – Richard M. Elliott (1954–2015). Journal of General Virology, 96(8), pp. 1975-1978. (doi: 10.1099/jgv.0.000241) (PMID:26315040)

Addie, D. D. et al. (2015) Disinfectant choices in veterinary practices, shelters and households: ABCD guidelines on safe and effective disinfection for feline environments. Journal of Feline Medicine and Surgery, 17(7), pp. 594-605. (doi: 10.1177/1098612X15588450) (PMID:26101311)

Egberink, H. et al. (2015) West Nile virus infection in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 617-619. (doi: 10.1177/1098612X15588453) (PMID:26101314)

Frymus, T. et al. (2015) Streptococcal infections in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 620-625. (doi: 10.1177/1098612X15588454) (PMID:26101315)

Hartmann, K. et al. (2015) Feline injection-site sarcoma: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 606-613. (doi: 10.1177/1098612X15588451) (PMID:26101312)

Hosie, M. J. et al. (2015) Matrix vaccination guidelines: 2015 ABCD recommendations for indoor/outdoor cats, rescue shelter cats and breeding catteries. Journal of Feline Medicine and Surgery, 17(7), pp. 583-587. (doi: 10.1177/1098612X15590732) (PMID:26101309)

Lloret, A. et al. (2015) Cytauxzoonosis in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 637-641. (doi: 10.1177/1098612X15589878) (PMID:26101317)

Lloret, A. et al. (2015) Hepatozoonosis in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 642-644. (doi: 10.1177/1098612X15589879) (PMID:26101318)

Lutz, H. et al. (2015) Borna disease virus infection in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 614-616. (doi: 10.1177/1098612X15588452) (PMID:26101313)

Mostl, K. et al. (2015) Something old, something new: update of the 2009 and 2013 ABCD guidelines on prevention and management of feline infectious diseases. Journal of Feline Medicine and Surgery, 17(7), pp. 570-582. (doi: 10.1177/1098612X15588448) (PMID:26101308)

Pennisi, M. G. et al. (2015) Lungworm disease in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), pp. 626-636. (doi: 10.1177/1098612X15588455) (PMID:26101316)

Pennisi, M. G. et al. (2015) Blood transfusion in cats: ABCD guidelines for minimising risks of infectious iatrogenic complications. Journal of Feline Medicine and Surgery, 17(7), pp. 588-593. (doi: 10.1177/1098612X15588449) (PMID:26101310)

Lehmann, M., Weber, K., Rauch, G., Hofmann-Lehmann, R., Hosie, M. , Meli, M. and Hartmann, K. (2015) Efficacy of siRNA on feline leukemia virus replication in vitro. Berliner und Munchener Tierarztliche Wochenschrift, 128(56), pp. 209-217. (doi: 10.2376/0005-0366-128-200)

Beczkowski, P. M., Hughes, J. , Biek, R. , Litster, A., Willett, B. J. and Hosie, M. J. (2015) Rapid evolution of the env gene leader sequence in cats naturally infected with feline immunodeficiency virus (FIV). Journal of General Virology, 96(4), pp. 893-903. (doi: 10.1099/vir.0.000035) (PMID:25535323) (PMCID:PMC4361796)

Beczkowski, P., Logan, N., McMonagle, E., Litster, A., Willett, B. J. and Hosie, M. J. (2015) An investigation of the breadth of neutralising antibody response in cats naturally infected with feline immunodeficiency virus. Journal of General Virology, 96(3), pp. 671-680. (doi: 10.1099/vir.0.071522-0) (PMID:25395594) (PMCID:PMC4336861)

Bęczkowski, P. M., Litster, A., Lin, T. L., Mellor, D. J. , Willett, B. J. and Hosie, M. J. (2015) Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV). Veterinary Microbiology, 176(1-2), pp. 50-60. (doi: 10.1016/j.vetmic.2014.12.023) (PMID:25595267) (PMCID:PMC4332694)

Boesch, A., Cattori, V., Riond, B., Willi, B., Meli, M. L., Rentsch, K. M., Hosie, M. J. , Hofmann-Lehmann, R. and Lutz, H. (2015) Evaluation of the effect of short-term treatment with the integrase inhibitor raltegravir (Isentress™) on the course of progressive feline leukemia virus infection. Veterinary Microbiology, 175(2-4), pp. 167-178. (doi: 10.1016/j.vetmic.2014.10.031) (PMID:25500005)

Beczkowski, P. M., Harris, M., Techakriengkrai, N., Beatty, J. A., Willett, B. J. and Hosie, M. J. (2015) Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine. Vaccine, 33(8), pp. 977-984. (doi: 10.1016/j.vaccine.2015.01.028) (PMID:25613718) (PMCID:PMC4327927)

Beczkowski, P. M., Techakriengkrai, N., Logan, N., McMonagle, E., Litster, A., Willett, B. J. and Hosie, M. J. (2014) Emergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats. Retrovirology, 11, p. 95. (doi: 10.1186/s12977-014-0095-7) (PMID:25430586) (PMCID:PMC4275942)

Bęczkowski, P. M., Hughes, J. , Biek, R. , Litster, A., Willett, B. J. and Hosie, M. J. (2014) Feline immunodeficiency virus (FIV) env recombinants are common in natural infections. Retrovirology, 11(80), (doi: 10.1186/s12977-014-0080-1) (PMID:25699660) (PMCID:PMC4180853)

Willett, B.J. and Hosie, M.J. (2013) The virus–receptor interaction in the replication of feline immunodeficiency virus (FIV). Current Opinion in Virology, 3(6), pp. 670-675. (doi: 10.1016/j.coviro.2013.08.003)

Chan, C.N., Dietrich, I., Hosie, M.J. and Willett, B.J. (2013) Recent developments in human immunodeficiency virus-1 latency research. Journal of General Virology, 94(5), pp. 917-932. (doi: 10.1099/vir.0.049296-0)

Chan, C.N., McMonagle, E.L., Hosie, M.J. and Willett, B.J. (2013) Prostratin exhibits both replication enhancing and inhibiting effects on FIV infection of feline CD4+ T-cells. Virus Research, 171(1), pp. 121-128. (doi: 10.1016/j.virusres.2012.11.004)

Stewart, H., Jarrett, O., Hosie, M.J. and Willett, B.J. (2013) Complete genome sequences of two feline Leukemia virus subgroup B isolates with novel recombination sites. Genome Announcements, 1(1), e00036-12. (doi: 10.1128/genomeA.00036-12)

Willett, B.J. and Hosie, M.J. (2013) Feline leukaemia virus: half a century since its discovery. Veterinary Journal, 195(1), pp. 16-23. (doi: 10.1016/j.tvjl.2012.07.004)

Willett, B.J. , Kraase, M., Logan, N., McMonagle, E., Varela, M. and Hosie, M.J. (2013) Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispecies. PLoS ONE, 8(1), e54871. (doi: 10.1371/journal.pone.0054871) (PMID:23372784) (PMCID:PMC3553009)

Stewart, H., Adema, K. W., McMonagle, E. L., Hosie, M. J. and Willett, B. J. (2012) Identification of novel subgroup a variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus. Retrovirology, 9, 48. (doi: 10.1186/1742-4690-9-48) (PMID:22650160) (PMCID:PMC3403869)

Teixeira, B.M., Hagiwara, M.K., Cruz, J.C.M. and Hosie, M.J. (2012) Feline immunodeficiency virus in South America. Viruses, 4(3), pp. 383-396. (doi: 10.3390/v4030383)

Dietrich, I., Hosie, M. J. and Willett, B. J. (2011) The role of BST2/tetherin in feline retrovirus infection. Veterinary Immunology and Immunopathology, 143(3-4), pp. 255-264. (doi: 10.1016/j.vetimm.2011.06.020)

Dietrich, I., McEwan, W. A., Hosie, M. J. and Willett, B. J. (2011) Restriction of the felid lentiviruses by a synthetic feline TRIM5-CypA fusion. Veterinary Immunology and Immunopathology, 143(3-4), pp. 235-242. (doi: 10.1016/j.vetimm.2011.06.017)

Stewart, H., Jarrett, O., Hosie, M.J. and Willett, B.J. (2011) Are endogenous feline leukemia viruses really endogenous? Veterinary Immunology and Immunopathology, 143(3-4), pp. 325-331. (doi: 10.1016/j.vetimm.2011.06.011)

Hosie, M. J. , Pajek, D., Samman, A. and Willett, B. J. (2011) Feline immunodeficiency virus (FIV) neutralization: a review. Viruses, 3(10), pp. 1870-1890. (doi: 10.3390/v3101870)

Teixeira, B.M., Logan, N., Samman, A., Miyashiro, S.I., Brandão, P.E., Willett, B.J. , Hosie, M.J. and Hagiwara, M.K. (2011) Isolation and partial characterization of Brazilian samples of feline immunodeficiency virus. Virus Research, 160(1-2), pp. 59-65. (doi: 10.1016/j.virusres.2011.05.007)

Dietrich, I., McMonagle, E. L., Petit, S. J., Vijayakrishnan, S. , Logan, N., Chan, C. N., Towers, G. J., Hosie, M. J. and Willett, B. J. (2011) Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection. Journal of Virology, 85(12), pp. 5840-5852. (doi: 10.1128/JVI.00071-11) (PMID:21490095) (PMCID:PMC3126296)

Samman, A., McMonagle, E.L., Logan, N., Willett, B.J. , Biek, R. and Hosie, M.J. (2011) Phylogenetic characterisation of naturally occurring feline immunodeficiency virus in the United Kingdom. Veterinary Microbiology, 150(3-4), pp. 239-247. (doi: 10.1016/j.vetmic.2011.01.027)

Dietrich, I., MacIntyre, A., McMonagle, E., Price, A.J., James, L.C., McEwan, W.A., Hosie, M.J. and Willett, B.J. (2010) Potent lentiviral restriction by a synthetic feline TRIM5 cyclophilin A fusion. Journal of Virology, 84(17), pp. 8980-8985. (doi: 10.1128/JVI.00858-10)

Willett, B. J., Kraase, M., Logan, N., McMonagle, E. L., Samman, A. and Hosie, M. J. (2010) Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody. Retrovirology, 7(1), p. 38. (doi: 10.1186/1742-4690-7-38) (PMID:20420700) (PMCID:PMC2873508)

Kraase, M., Sloan, R., Klein, D., Logan, N., McMonagle, L., Biek, R. , Willett, B. J. and Hosie, M. J. (2010) Feline immunodeficiency virus env gene evolution in experimentally infected cats. Veterinary Immunology and Immunopathology, 134(1-2), pp. 96-106. (doi: 10.1016/j.vetimm.2009.10.015) (PMID:19897254)

Teixeira, B. M., Logan, N., Cruz, J.C.M., Reis, J.K.P., Brandão, P.E., Richtzenhain, L.J., Hagiwara, M.K., Willett, B.J. and Hosie, M.J. (2010) Genetic diversity of Brazilian isolates of feline immunodeficiency virus. Archives of Virology, 155(3), pp. 379-384. (doi: 10.1007/s00705-009-0587-2)

Samman, A., Logan, N., McMonagle, E. L., Ishida, T., Mochizuki, M., Willett, B. J. and Hosie, M. J. (2010) Neutralization of feline immunodeficiency virus by antibodies targeting the V5 loop of Env. Journal of General Virology, 91(1), pp. 242-249. (doi: 10.1099/vir.0.015404-0)

Fletcher, N.F., Bexiga, M.G., Brayden, D.J., Brankin, B., Willett, B.J., Hosie, M.J., Jacque, J.M. and Callanan, J.J. (2009) Lymphocyte migration through the blood brain barrier (BBB) in feline immunodeficiency virus infection is significantly influenced by the pre-existence of virus and TNF-α within the CNS: studies using an in vitro feline BBB model. Neuropathology and Applied Neurobiology, 35(6), pp. 592-602. (doi: 10.1111/j.1365-2990.2009.01031.x)

McEwan, W. A., Schaller, T., Ylinen, L. M., Hosie, M. J., Towers, G. J. and Willett, B. J. (2009) Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat. Journal of Virology, 83(16), pp. 8270-8275. (doi: 10.1128/JVI.00670-09) (PMID:19494015) (PMCID:PMC2715776)

Addie, D. et al. (2009) Feline infectious peritonitis. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 594-604. (doi: 10.1016/j.jfms.2009.05.008)

Egberink, H. et al. (2009) Bordetella bronchiseptica infection in cats. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 610-614. (doi: 10.1016/j.jfms.2009.05.010)

Frymus, T. et al. (2009) Feline rabies. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 585-593. (doi: 10.1016/j.jfms.2009.05.007)

Gruffydd-Jones, T. et al. (2009) Chlamydophila felis infection. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 605-609. (doi: 10.1016/j.jfms.2009.05.009)

Hosie, M. J. et al. (2009) Feline immunodeficiency. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 575-584. (doi: 10.1016/j.jfms.2009.05.006)

Lutz, H. et al. (2009) Feline leukaemia. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 565-574. (doi: 10.1016/j.jfms.2009.05.005)

Radford, A. D. et al. (2009) Feline calicivirus infection. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 556-564. (doi: 10.1016/j.jfms.2009.05.004)

Thiry, E. et al. (2009) H5N1 avian influenza in cats. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 615-618. (doi: 10.1016/j.jfms.2009.05.011)

Thiry, E. et al. (2009) Feline herpesvirus infection. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 547-555. (doi: 10.1016/j.jfms.2009.05.003)

Truyen, U. et al. (2009) Feline panleukopenia. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), pp. 538-546. (doi: 10.1016/j.jfms.2009.05.002)

Willett, B. J., McMonagle, E. L., Logan, N., Schneider, P. and Hosie, M. J. (2009) Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus. Molecular Immunology, 46(6), pp. 1020-1030. (doi: 10.1016/j.molimm.2008.08.271)

McEwan, W. A., McMonagle, E. L., Logan, N., Serra, R. C., Kat, P., Vandewoude, S., Hosie, M. J. and Willett, B. J. (2008) Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors. Journal of Virology, 82(21), pp. 10953-10958. (doi: 10.1128/JVI.01312-08)

Addie, D., Poulet, H., Golder, M.C., McDonald, M. , Brunet, S., Thibault, J.-C. and Hosie, M.J. (2008) Ability of antibodies to two new caliciviral vaccine strains to neutralise feline calicivirus isolates from the UK. Veterinary Record, 163(12), pp. 355-7. (doi: 10.1136/vr.163.12.355)

Willett, B. J., McMonagle, E. L., Logan, N., Samman, A. and Hosie, M. J. (2008) A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction. Retrovirology, 5(77), (doi: 10.1186/1742-4690-5-77)

Willett, B. J. and Hosie, M. J. (2008) Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection. Veterinary Immunology and Immunopathology, 123(1-2), pp. 56-64. (doi: 10.1016/j.vetimm.2008.01.012)

Fletcher, N.F., Bexiga, M., Brayden, D.J., Brankin, B., Willett, B.J. , Hosie, M.J. , Jacque, J.M. and Callanan, J.J. (2008) Cell migration through the blood brain barrier (BBB) in feline immunodeficiency virus infection is significantly influenced by the pre-existence of virus and tnf-alpha within the CNS: studies using an in vitro feline BBB model. Journal of Neuroimmunology, 197(2), p. 161.

Hosie, M. J. and Beatty, J. A. (2007) Vaccine protection against feline immunodeficiency virus: setting the challenge. Australian Veterinary Journal, 85(1-2), pp. 5-12. (doi: 10.1111/j.1751-0813.2006.00071.x)

Willett, B.J., McMonagle, E.L., Logan, N., Spiller, O.B., Schneider, P. and Hosie, M.J. (2007) Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligand. Journal of Virology, 81(18), pp. 9665-9679. (doi: 10.1128/JVI.01020-07)

Willett, B.J., McMonagle, E.L., Bonci, F., Pistello, M. and Hosie, M.J. (2006) Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus (FIV). Journal of Virology, 80(15), pp. 7744-7747. (doi: 10.1128/JVI.00722-06)

Willett, B.J., McMonagle, E.L., Ridha, S. and Hosie, M.J. (2006) Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus. Journal of Virology, 80(7), pp. 3386-3394. (doi: 10.1128/JVI.80.7.3386-3394.2006)

Willett, B., McMonagle, E., Bonci, F., Pistello, M. and Hosie, M. (2006) Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus. Journal of Virology, 80, pp. 7744-7747. (doi: 10.1128/JVI.00722-06)

Hosie, M.J. et al. (2005) Vaccination with an Inactivated Virulent Feline Immunodeficiency Virus Engineered to Express High Levels of Env. Journal of Virology, 79(3), pp. 1954-1957.

Ryan, G., Grimes, T., Brankin, B., Mabruk, M., Hosie, M., Jarrett, O. and Callanan, J. (2005) Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers. Journal of Neurovirology, 11, pp. 337-345. (doi: 10.1080/13550280500186445)

Tebb, A.J., Cave, T., Barron, R., Brown, A.L., Martineau, H.M., Willett, B. and Hosie, M.J. (2004) Diagnosis and management of β cell chronic lymphocytic leukaemia in a cat. Veterinary Record, 154(14), pp. 430-433. (doi: 10.1136/vr.154.14.430)

Shimojima, M., Miyazawa, T., Ikeda, Y., McMonagle, E.L., Haining, H., Akashi, H., Takeuchi, Y., Hosie, M.J. and Willett, B.J. (2004) Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science, 303(20), pp. 1192-1195. (doi: 10.1126/science.1092124)

Ryan, G., Klein, D., Knapp, E., Hosie, M., Grimes, T., Mabruk, M., Jarrett, O. and Callanan, J. (2003) Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection. Journal of Virology, 77, pp. 7477-7485. (doi: 10.1128/JVI.77.13.7477-7485.2003)

Willett, B.J., Cannon, C.A. and Hosie, M.J. (2003) Expression of CXCR4 on feline peripheral blood mononuclear cells: effect of feline immunodeficiency virus infection. Journal of Virology, 77(1), pp. 709-712. (doi: 10.1128/JVI.77.1.709-712.2003)

Brown, A., Dunsford, T., Jarrett, O., Willett, B. and Hosie, M. (2002) Demonstration of biological activity of CD40 ligand (CD154) in the domestic cat. Cytokine, 17, pp. 140-148. (doi: 10.1006/cyto.2001.0993)

Hosie, M.J. , Willett, B.J. , Klein, D., Dunsford, T.H., Cannon, C., Shimojima, M., Neil, J.C. and Jarrett, O. (2002) Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. Journal of Virology, 76(12), pp. 6062-6072. (doi: 10.1128/JVI.76.12.6062-6072.2002)

Lawson, M.H. and Hosie, M.J. (2001) Follow up of feline immunodeficiency virus-infected cats. Veterinary Record, 148(14), pp. 449-450. (doi: 10.1136/vr.148.14.449)

Hosie, M.J. et al. (2000) Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. Journal of Virology, 74(20), pp. 9403-9411. (doi: 10.1128/JVI.74.20.9403-9411.2000)

Flynn, J.N., Hosie, M.J. , Rigby, M.A., Mackay, N., Cannon, C.A., Dunsford, T., Neil, J.C. and Jarrett, O. (2000) Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination. Vaccine, 18(11-12), pp. 1118-1132. (doi: 10.1016/S0264-410X(99)00375-8) (PMID:10590334)

Willett, B.J. and Hosie, M.J. (1999) The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus. Molecular Membrane Biology, 16(1), pp. 67-72. (doi: 10.1080/096876899294779)

Hosie, M.J. et al. (1998) DNA vaccination affords significant protection against feline immunodeficiency virus without inducing detectable antiviral antibodies. Journal of Virology, 72(9), pp. 7310-7319.

Willett, B.J. et al. (1998) The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. Journal of Virology, 72(8), pp. 6475-6481.

Hosie, M.J. , Broere, N., Hesselgesser, J., Turner, J.D., Hoxie, J.A., Neil, J.C. and Willett, B.J. (1998) Modulation of feline immunodeficiency virus infection by stromal cell-derived factor (SDF-1). Journal of Virology, 72(3), pp. 2097-2104.

Rigby, M.A., Hosie, M.J., Willett, B.J., Mackay, N., McDonald, M., Cannon, C., Dunsford, T., Jarrett, O. and Neil, J.C. (1997) Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation. AIDS Research and Human Retroviruses, 13(5), pp. 405-12. (doi: 10.1089/aid.1997.13.405) (PMID:9075482)

Willett, B. , Hosie, M. , Shaw, A. and Neil, J.C. (1997) Inhibition of feline immunodeficiency virus infection by CD9 antibody operates after virus entry and is independent of virus tropism. Journal of General Virology, 78(3), pp. 611-618. (doi: 10.1099/0022-1317-78-3-611)

Willett, B.J., Flynn, J.N. and Hosie, M.J. (1997) FIV infection of the domestic cat: an animal model for AIDS. Immunology Today, 18(4), pp. 182-9.

Willett, B.J., Hosie, M.J. , Neil, J.C. , Turner, J.D. and Hoxie, J.A. (1997) Common mechanism of infection by lentiviruses. Nature, 385(6617), p. 587. (doi: 10.1038/385587a0)

Flynn, J.N., Keating, P., Hosie, M.J. , Mackett, M., Stephens, E.B., Beatty, J.A., Neil, J.C. and Jarrett, O. (1996) Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. Journal of Immunology, 157(8), pp. 3658-65. (PMID:8871667)

Hosie, M.J., Dunsford, T.H., de Ronde, A., Willett, B.J., Cannon, C.A., Neil, J.C. and Jarrett, O. (1996) Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine, 14(5), pp. 405-411. (doi: 10.1016/0264-410X(95)00193-5)

Hosie, M.J. , Osborne, R., Yamamoto, J.K., Neil, J.C. and Jarrett, O. (1995) Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. Journal of Virology, 69(2), pp. 1253-1255.

Flynn, J.N., Beatty, J.A., Cannon, C.A., Stephens, E.B., Hosie, M.J. , Neil, J.C. and Jarrett, O. (1995) Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Research and Human Retroviruses, 11(9), pp. 1107-1113. (doi: 10.1089/aid.1995.11.1107) (PMID:8554908)

Neil, J.C. et al. (1995) Development of AIDS vaccine strategies in a feline animal model. AIDS Research and Human Retroviruses, 11, S136.

Willett, B.J. , Hosie, M.J. , Jarrett, O. and Neil, J.C. (1994) Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology, 81(2), pp. 228-33. (PMID:8157271)

Hosie, M.J. , Willett, B.J. , Dunsford, T.H., Jarrett, O. and Neil, J.C. (1993) A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. Journal of Virology, 67(3), pp. 1667-1671. (PMID:7679750) (PMCID:PMC237540)

Willett, B.J. , Hosie, M. , Neil, J.C. and Jarrett, O. (1993) Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology, 78, pp. 1-6. (PMCID:PMC1421779)

Hosie, M. J. , Osborne, R., Reid, G., Neil, J. C. and Jarrett, O. (1992) Enhancement after feline immunodeficiency virus vaccination. Veterinary Immunology and Immunopathology, 35(1-2), pp. 191-197. (doi: 10.1016/0165-2427(92)90131-9) (PMID:1337397)

Willett, B.J. , Hosie, M.J. , Dunsford, T.H., Neil, J.C. and Jarrett, O. (1991) Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS, 5(12), pp. 1469-75. (PMID:1687647)

Book Sections

Willett, B.J. and Hosie, M.J. (2010) The felid immunodeficiency viruses: viral cell tropism and the pathogenesis of feline AIDS. In: Desport, M. (ed.) Lentiviruses and Macrophages. Horizon Scientific Press. ISBN 9781904455608

Conference or Workshop Item

Ogawa, S., Sherry, L. and Hosie, M. (2024) High Resolution Structure of a Clinical Respiratory Isolate of Feline Calicivirus Determined by Cryo-EM. British Small Animal Veterinary Association (BSAVA) Congress 2024, Manchester, UK, 21-23 Mar 2024. ISBN 9781913859411 (doi: 10.22233/9781913859411.45.3)

This list was generated on Mon Nov 18 23:04:56 2024 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Understanding the molecular characteristics of virulent systemic feline calicivirus infection
    Petplan Charitable Trust
    2024 - 2028
     
  • SARS-CoV-2 infections in cats: assessing their zoonotic potential and role in sustaining the pandemic
    Biotechnology and Biological Sciences Research Council
    2021 - 2022
     
  • UKRI COVID-19 website
    Medical Research Council
    2020 - 2020
     
  • Host and viral factors in the emergence of a virulent strain of calicivirus
    Biotechnology and Biological Sciences Research Council
    2020 - 2022
     
  • Inspire Round 5 - vet school
    Academy of Medical Sciences
    2020 - 2021
     
  • A One Health approach to pan-valent morbillivirus vaccines
    Biotechnology and Biological Sciences Research Council
    2018 - 2021
     
  • Atypical bovine morbillivirus infections in the Serengeti ecosystem
    Biotechnology and Biological Sciences Research Council
    2017 - 2020
     
  • Quinquennial Core Funds
    Medical Research Council
    2016 - 2021
     
  • A viral pseudotype based approach to measuring morbillivirus neutralising antibodies
    Biotechnology and Biological Sciences Research Council
    2015 - 2017
     
  • The Centre for Virus Research
    Wellcome Trust
    2015 - 2020
     
  • Developing an algorithm to predict the outcome for cats infected with feline immunodeficiency virus
    Petplan Charitable Trust
    2014 - 2014
     
  • Identification of a novel viral agent in feline immunodeficiency virus (FIV)-associated lymphomagenesis (ISSF Catalyst Fund)
    Wellcome Trust
    2011 - 2014
     
  • Centre for Virus Research
    Medical Research Council
    2010 - 2016
     
  • Centre for Integrated Virology
    Medical Research Council
    2010 - 2015
     
  • Quasispecies evolution in the progression of FIV infectionttttrnttttrn
    Wellcome Trust
    2009 - 2017
     
  • The virus-receptor interaction in lentiviral pathogenesis and immunity
    Wellcome Trust
    2008 - 2013
     
  • Control of Feline Immunodeficiency Virus Infection
    Biotechnology and Biological Sciences Research Council
    2006 - 2009
     
  • Rational Design of a Lentiviral Vaccine
    Medical Research Council
    2004 - 2007
     
  • Receptor Usage and Pathogenicity of Feline Lentiviruses
    National Institute of Health
    2003 - 2009
     

Supervision

  • Tyson, Grace
    Investigating SARS-CoV-2 infection in UK cats: prevalence and significance as a feline pathogen

Research datasets

Jump to: 2020
Number of items: 1.

2020

Gilbert, M., Sulikhan, N., Uphyrkina, O., Goncharuk, M., Kerley, L., Hernandez Castro, E., Reeve, R. , Seimon, T., McAloose, D., Seryodkin, I. V., Naidenko, S. V., Davis, C. A., Wilkie, G. S., Vattipally, S. , Adamson, W., Hinds, C., Thomson, E. , Willett, B. , Hosie, M. , Logan, N., McDonald, M. , Ossiboff, R. J., Shevtsova, E. I., Belyakin, S., Yurlova, A. A., Osofsky, S. A., Miquelle, D. G., Matthews, L. and Cleaveland, S. (2020) Distemper, extinction and vaccination of the Amur tiger. [Data Collection]

This list was generated on Tue Nov 19 02:27:31 2024 GMT.

Additional information

Editorial Board

  • 2008 - present: Veterinary Microbiology
  • 2007 - present: Virus Genes

Grant Advisory Board

  • 2010 - 2011: Swiss National Science Foundation - Expert Assessor
  • 2009 - 2011: National Institutes of Health - Special Emphasis Panel “Basic HIV Vaccine Discovery Research (R01)”
  • 2008 - present: European Medicines Agency - Experts' Database
  • 2007 - present: DEFRA - Peer reviewer database
  • 2005 - present: SEERAD - Science and Research Group peer reviewer

Invited International Presentations

  • 2010: Amsterdam, The Netherlands - Seminar Speaker, “Kring Dierenartsen Amsterdam”
  • 2009: Vienna, Austria - Guest Lecture, University of Vienna
  • 2008: Edinburgh, UK - Plenary Speaker, European Society for Feline Medicine Conference
  • 2007: Rome, Italy - Plenary Speaker, Advisory Board Cat Diseases meeting
  • 2005: Lyon, France - Plenary Speaker, Advisory Board Cat Diseases meeting
  • 2005: Liverpool, UK - International Congress of Veterinary Virology

Prizes, Awards and Distinctions

  • : Royal College of Veterinary Surgeons - Recognised Specialist in Pathology (Microbiology) 2008-2013
  • : Royal College of Veterinary Surgeons - Recognised Specialist in Pathology (Microbiology) 2002-2007

Professional Learned Society

  • 2005 - present: European Advisory Board for Cat Diseases - Board Member

Visit the Hosie Group webpage

MRC, University of Glasgow and CVR logos